Science Explorer Back to mapMap
Discussion
Researcher · Consejo Nacional de Investigaciones Científicas y Técnicas · Argentina

Fernando Pablo Canale

Fernando Pablo Canale publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and T-cell and B-cell Immunology.

ORCID 0000-0001-5805-6785 OpenAlex
World rank
#2,110,042
of 7,710,434 ranked researchers
Rank in Argentina
#3,894
of 38,473
Works
31
Citations
1.6k
Citations per work
51.8
h-index
12
i10-index 12Top 63% in Immunology
Fernando Pablo Canale

What does Fernando Pablo Canale research?

Fernando Pablo Canale's work is mostly in Immunology and Microbiology (35%), Medicine (26%), Biochemistry, Genetics and Molecular Biology (13%).

Life Sciences: 16 works · 50.7% of their workImmunology and Microbiology: 11 works · 34.8% of their workImmunology: 11 works · 34.8% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 13.0% of their workMolecular Biology: 2 works · 5.8% of their workBiotechnology: 1 works · 4.3% of their workGenetics: 1 works · 2.9% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 2.9% of their workPharmacology: 1 works · 2.9% of their workHealth Sciences: 8 works · 26.1% of their workMedicine: 8 works · 26.1% of their workOncology: 8 works · 26.1% of their workEverything else: 7 works · 23.2% of their workTHEIR WORKFernando PabloCanale31works
Life Sciences51%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1134.8%
    2. Biochemistry, Genetics and Molecular Biology413.0%
    3. Pharmacology, Toxicology and Pharmaceutics12.9%
    1. Medicine826.1%
  3. Everything else723.2%
  1. 1Immunology35% of their works
  2. 2Oncology26% of their works
  3. 3Molecular Biology6% of their works
  4. 4Biotechnology4% of their works
  5. 5Genetics3% of their works
  6. 6Pharmacology3% of their works

Research topics

Which keywords describe Fernando Pablo Canale's research?

The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Immunity, Immunotherapy and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Immune Checkpoint Blockade101 topic
  2. PD-1 and PD-L1101 topic
  3. NK Cell Recognition91 topic
  4. Natural Killer Cells91 topic
  5. Cancer Immunotherapy72 topics
  6. Immunity72 topics
  7. Immunotherapy72 topics
  8. Foxp351 topic
  9. Gene Therapy52 topics
  10. TGF-ß51 topic
  11. Activation41 topic
  12. CAR T Cells41 topic
  13. Chimeric Antigen Receptor41 topic
  14. Macrophage41 topic
  15. Antigen Presentation31 topic
  16. Bacterial Therapy31 topic
  17. Dendritic Cells31 topic
  18. Tumor Targeting31 topic
  19. AAV21 topic
  20. Viral Vectors21 topic

Where does Fernando Pablo Canale work?

Fernando Pablo Canale's main affiliation in the publication record is Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina.

How many publications and citations does Fernando Pablo Canale have?

OpenAlex counts 31 works and 1,605 citations for Fernando Pablo Canale, an h-index of 12, ranking #2,110,042 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fernando Pablo Canale. Posts are plain text and can be reported.